Please login to the form below

Not currently logged in
Email:
Password:

F-Star

This page shows the latest F-Star news and features for those working in and with pharma, biotech and healthcare.

BMS taps F-star Alpha for immuno-oncology drug

BMS taps F-star Alpha for immuno-oncology drug

BMS taps F-star Alpha for immuno-oncology drug. Drug in development for breast and stomach cancers. ... F-star has its headquarters in Vienna but runs its research operations out of the Babraham Research Campus in Cambridge, UK.

Latest news

  • f-star wins €15m investment

    f-star wins 15m investment. Antibody specialist f-star secures funding from existing investors and adds new members to its supervisory board. ... f-star, a company developing antibody-based products, has secured 15m of new financing.

  • Survival strategy

    During November and December 2010 there were five Big Pharma discovery deals involving Boehringer Ingelheim (with f-star), S-A (with Avila Therapeutics), Pfizer (with Phylogica), Tanabe Research Laboratories (with Anaphore) ... 286. Aires/Novartis.

  • PM Society Awards 2005

    These days you're lucky if you can give them a three-star hotel and a f ing biro. ... He also issued a thinly-veiled warning to any entrants who had been honoured with a highly commended': Congratulations and all that but stay in your f ing seat.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    525. F-star Alpha/BMS. Option to acquire F-star Alpha. Includes FS102 a P1 ready treatment for HER2 positive patients with breast / gastric cancer.

  • Pharma deals during October 2014 Pharma deals during October 2014

    This month is no exception with Bristol-Myers Squibb (BMS) securing an exclusive option to acquire F-star Alpha gaining access to its lead candidate FS102 for HER-2 positive patients

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • ImmuneXcite boosts senior leadership ImmuneXcite boosts senior leadership

    Edwards is currently executive chairman at F-star, having previously served as its chief executive officer, and brings over 30 years of biotechnology expertise from Adnexus Therapeutics, Genetics Institute/Wyeth and

  • F-star appoints vice president of protein sciences F-star appoints vice president of protein sciences

    F-star appoints vice president of protein sciences. Mike Davies joins from CPI Biologics. ... Vienna-headquartered biopharmaceutical company F-star has appointed Mike Davies as vice president of protein sciences at its Cambridge, UK research site.

  • F-star appoints GSK's Neil Brewis F-star appoints GSK's Neil Brewis

    Cambridge-based antibody research company F-Star has appointed Dr Neil Brewis as chief scientific officer. ... John Haurum CEO of F-Star, said: “ We are very pleased to welcome Neil to our team.

  • ReNeuron makes shifts and additions to senior team ReNeuron makes shifts and additions to senior team

    Grimster has extensive experience in advanced biologics development as has served in senior developments roles at businesses including F-star, Antisoma and Celltech.

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics